Related Experiment Video
Updated: Jul 19, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Ibogaine affects brain energy metabolism
Roman Paskulin1, Polona Jamnik, Marko Zivin
1OMI Institute, Trnovska 8, Ljubljana, Slovenia. roman.paskulin@siol.net
European Journal of Pharmacology
|October 24, 2006
Summary
Ibogaine, an anti-addiction compound, alters brain protein expression, specifically inducing key metabolic enzymes. This suggests ibogaine
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Ibogaine, an indole alkaloid from *Tabernanthe iboga*, shows promise in attenuating drug addiction withdrawal symptoms.
- Its long-lasting anti-addiction effects suggest significant, yet uncharacterized, metabolic alterations in the brain.
Purpose of the Study:
- To investigate the impact of ibogaine on protein expression in rat brains.
- To identify specific proteins and metabolic pathways affected by ibogaine treatment.
Main Methods:
- Rats received intraperitoneal injections of ibogaine (20 mg/kg).
- Brain proteins were extracted and analyzed using two-dimensional (2-D) electrophoresis.
- Protein identification was performed using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).
Main Results:
- Ibogaine treatment induced specific enzymes involved in glycolysis and the tricarboxylic acid (TCA) cycle.
- Identified enzymes include glyceraldehyde-3-phosphate dehydrogenase, aldolase A, pyruvate kinase, and malate dehydrogenase.
- These changes were observed at 24 and 72 hours post-treatment.
Conclusions:
- The anti-addiction effects of ibogaine may be mediated by enhanced cellular energy metabolism.
- Increased metabolic turnover could support the functional and structural cellular changes required for detoxification and tolerance reversion.
- This study highlights the subcellular metabolic underpinnings of addiction and anti-addiction drug action.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...